During this summer of 2024, there was a study presented at the Alzheimers Association International Conference in Philadelphia that weight loss medication can slow cognitive decline
PMC+1 Goldberg AS, Boots CE
1m45s Society is largely unprepared for the end-of-life passage, as evidenced by the rarity of discussions regarding palliative care compared to other health topics
Frequently Asked Questions Rybelsus is a daily tablet containing semaglutide, originally approved for type 2 diabetes
In an open-label consumer perception survey, BC30 Probiotic shows potential for maintaining digestive comfort, supporting continued GLP-1 use and enhancing overall satisfaction among users In an open-label consumer perception survey, BC30 Probiotic shows potential for maintaining digestive comfort, supporting continued GLP-1 use and enhancing overall satisfaction among users Naas, Ireland (June 4, 2025) Kerry Group, a global leader in taste and nutrition solutions, released a new consumer perception study suggesting its scientifically-backed BC30 Probiotic contributed to a positive experience among users of GLP-1 (glucagon-like peptide-1) medications a class of drugs growing rapidly for weight management and type 2 diabetes
E.BeaudinS